Literature DB >> 2403176

False-negative syphilis screening: the prozone phenomenon, nonimmune hydrops, and diagnosis of syphilis during pregnancy.

K Berkowitz1, L Baxi, H E Fox.   

Abstract

The prevalence of congenital syphilis is rapidly rising in several areas of the United States. Efforts to control the disease depend on the effectiveness of established screening strategies and treatment of infected pregnant women. False-negative test results hinder these efforts and leave the fetus at risk for acquiring congenital syphilis. Recently we encountered four cases of false-negative syphilis serologic results in women who gave birth to infants with congenital syphilis. The false-negative results were caused by the prozone phenomenon. The prozone phenomenon, seen during primary and secondary syphilis, occurs because a higher than optimal amount of antibody in the tested sera prevents the flocculation reaction typifying a positive result in reagin tests. Serum dilution is necessary to make the correct diagnosis. We recommend that for any pregnant woman with apparently negative syphilis serologic results in whom fetal compromise of unknown etiology exists, particularly nonimmune hydrops, nontreponemal testing should be repeated using serum dilutions to prevent a missed diagnosis of syphilis. We further recommend serum dilution as a routine procedure for all pregnant women in areas of high syphilis prevalence.

Entities:  

Mesh:

Year:  1990        PMID: 2403176     DOI: 10.1016/0002-9378(90)91107-n

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

1.  Validation of the INNO-LIA syphilis kit as a confirmatory assay for Treponema pallidum antibodies.

Authors:  A Ebel; L Vanneste; M Cardinaels; E Sablon; I Samson; K De Bosschere; F Hulstaert; M Zrein
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Performance of the rapid plasma reagin and the rapid syphilis screening tests in the diagnosis of syphilis in field conditions in rural Africa.

Authors:  B West; G Walraven; L Morison; J Brouwers; R Bailey
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

3.  Enzyme immunoassay for anti-treponemal IgG: screening or confirmatory test?

Authors:  H Young; A Moyes; A McMillan; J Patterson
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

Review 4.  The endemic treponematoses.

Authors:  Lorenzo Giacani; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

5.  Laboratory Evaluation of a Commercially Available Rapid Syphilis Test.

Authors:  Lara E Pereira; Joshua McCormick; Tandin Dorji; Joseph Kang; Yongcheng Sun; Mayur Shukla; Andre Hopkins; John Deutsch; Ellen N Kersh; Kyle Bernstein; Yetunde F Fakile
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

6.  Evaluation of a new competitive immunoassay (BioElisa Syphilis) for screening for Treponema pallidum antibodies at various stages of syphilis.

Authors:  A Ebel; L Bachelart; J M Alonso
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

Review 7.  Syphilis in pregnancy.

Authors:  M Genç; W J Ledger
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

8.  Comparison of CAPTIA syphilis G enzyme immunoassay with rapid plasma reagin test for detection of syphilis.

Authors:  R P Silletti
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

9.  Evaluation of a Rapid Immunochromatographic Treponemal Antibody Test Comparing the Treponema Pallidum Particle Agglutination Assay.

Authors:  Jong-Han Lee; Chae Seung Lim; Min-Geol Lee; Hyon-Suk Kim
Journal:  J Clin Lab Anal       Date:  2014-11-10       Impact factor: 2.352

10.  Recombinant antigen-based enzyme immunoassay for screening of Treponema pallidum antibodies in blood bank routine.

Authors:  M Zrein; I Maure; F Boursier; L Soufflet
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.